Spirotropane compounds and methods for the modulation of...

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C546S018000, C546S020000, C548S408000

Reexamination Certificate

active

08076349

ABSTRACT:
Compounds according to formula (I):wherein A, R1and R2are as defined herein, and the pharmaceutically acceptable salts, hydrates and solvates thereof are useful for the modulation of CCR5 chemokine receptor activity.

REFERENCES:
patent: 5407938 (1995-04-01), Fisher et al.
patent: 5534520 (1996-07-01), Fisher et al.
patent: 5852029 (1998-12-01), Fisher et al.
patent: 2310458 (1999-06-01), None
patent: WO 95/03303 (1995-02-01), None
patent: WO 01/66546 (2001-09-01), None
patent: WO 01/66546 (2001-09-01), None
patent: WO 02/13824 (2002-02-01), None
patent: WO 2004/041279 (2004-05-01), None
patent: WO 2005/007656 (2005-01-01), None
patent: WO 2005/023809 (2005-03-01), None
patent: WO 2005/023810 (2005-03-01), None
patent: WO 2005/000096 (2006-01-01), None
patent: WO 2006/060919 (2006-06-01), None
patent: WO 2007/143847 (2007-12-01), None
Dr. Rolf Eberbard Nitz, et al., Arzneimittel-Forschung, Jul. 1955, pp. 357-364.
Por A. Garcia Sacristan, et al., Arch. De Farmacol y Toxicol, 1977, pp. 57-66.
George W. Smith, et al., Journal of the American Chemical Society, Jul. 5, 1955, pp. 3541-3543.
International Preliminary Report on Patentability for International Application No. PCT/CA2005/001877 issued Jun. 13, 2007.
Written Opinion of the International Searching Authority for International Patent Application No. PCT/CA2005/001877 completed Mar. 15, 2006.
International Search Report for PCT/CA2005/001877 mailed Mar. 29, 2006.
Abstract of WO2001066546, Date: Sep. 13, 2001.
CAPLUS 77699151, Date: Oct. 26, 2010.
CAPLUS 72402245, Date: Oct. 26, 2010.
CAPLUS 64192796, Date: Oct. 26, 2010.
CAPLUS 64192774, Date: Oct. 26, 2010.
Abstract of Dr. Rolf Eberbard Nitz, et al., “Chemistry and anticonvulsive activity of new hydantoin derivatives” CAPLUS Accession No: 1956:2309 Copyright © 2008 ACS on SciFinder®.
Abstract of Por A. Garcia Sacristan, et al., “N-substituted nortropane hydantoins. Action on smooth muscle, and antiarrhythmic and anticonvulsant effects” Accession No. 1977:593826 CAPLUS Copyright © 2008 ACS on SciFinder®.
Dr. Rolf Eberbard Nitz, et al., Arzneimittel-Forschung, pp. 357-364, Jul. 1955.
Por A. Garcia Sacristan, et al., Arch. De. Farmacol y Toxicol, 1977, pp. 57-66.
International Search Report for International Application No. PCT/CA2007/001062 mailed Sep. 6, 2007.
International Search Report for International Application No. PCT/CA2005/001878 mailed Mar. 29, 2006.
Supplementary European Search Report for European Application No. 05 81 9431.7-2117 / 1831222 of Sep. 18, 2009.
Written Opinion of the International Searching Authority for International Application No. PCT/CA2005/001877 mailed Mar. 29, 2006.
Extended European Search Report in European Application No. 05 819 950.6-2101 / 1824853 dated Oct. 5, 2010.
International Search Report for International Application No. PCT/CA2005/001877 mailed Mar. 29, 2006.
International Search Report dated Jun. 21, 2007 corresponding to International Application PCT/CA2005/001877.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Spirotropane compounds and methods for the modulation of... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Spirotropane compounds and methods for the modulation of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirotropane compounds and methods for the modulation of... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4314309

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.